OPTN
Closed
Optinose
9.6
0.0 (0.00%)
Last Update: 21 May 2025 16:30:00
Yesterday: 9.6
Day's Range: 9.6 - 9.6
Send
sign up or login to leave a comment!
When Written:
1.86
OptiNose is a pharmaceutical company that develops and markets innovative nasal drug delivery systems. Their patented technology, called Exhalation Delivery System (EDS), is designed to deliver drugs deep into the nasal cavity, providing targeted and efficient treatment for various conditions such as migraines, allergies, and nasal polyps.
The company was founded in 2010 and is headquartered in Yardley, Pennsylvania. OptiNose has a diverse pipeline of products in various stages of development, including treatments for chronic obstructive pulmonary disease (COPD), cough, and autism spectrum disorders.
OptiNose is committed to improving the lives of patients through innovative drug delivery systems and has received several awards for its technology and products. The company is publicly traded on the NASDAQ stock exchange under the symbol OPTN.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company was founded in 2010 and is headquartered in Yardley, Pennsylvania. OptiNose has a diverse pipeline of products in various stages of development, including treatments for chronic obstructive pulmonary disease (COPD), cough, and autism spectrum disorders.
OptiNose is committed to improving the lives of patients through innovative drug delivery systems and has received several awards for its technology and products. The company is publicly traded on the NASDAQ stock exchange under the symbol OPTN.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








